Alexandria Venture Investments Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
3

- Investments
-
362
- Portfolio
-
155
- Exits
-
116

Alexandria Venture Investments General Information
Description
Founded in 1996, Alexandria Venture Investments is the corporate venture capital arm of Alexandria Real Estate Equities based in Pasadena, California. The firm prefers to invest in seed-stage, early-stage, and growth-stage companies operating in the healthcare, disruptive life science, agrifood technology, climate innovation, and information technology sectors.
Contact Information
Year Founded
1996
Investor Status
Actively Seeking New Investments
Trade Association
New England Venture Capital Association (NEVCA)
Primary Investor Type
Corporate Venture Capital
Primary Office
- 26 North Euclid Avenue
- Pasadena, CA 91101
- United States
+1 (626) 000-0000
Alexandria Venture Investments Investments (362)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Alto Neuroscience | 21-Nov-2023 | Later Stage VC | 0000 | Drug Discovery | Generating Revenue | |
Triveni Bio | 26-Oct-2023 | 00000 00000 | 000.00 | Drug Discovery | Clinical Trials - Phase 2 | |
DEKA Biosciences | 28-Sep-2023 | 00000 00000 | 0000 | Drug Discovery | Clinical Trials - Phase 1 | |
Arialys | 12-Sep-2023 | 0000 00000 | 0000 | Biotechnology | Startup | |
ROME Therapeutics | 12-Sep-2023 | 00000 00000 | 00000 | Drug Discovery | Pre-Clinical Trials | |
Georgiamune | 09-Aug-2023 | 00000 00000 | 0000 | Biotechnology | Clinical Trials - General | |
Neurogene | 18-Jul-2023 | 0000 | 0000 | Drug Discovery | Generating Revenue | |
AltPep | 22-Jun-2023 | 00000 00000 | 000.00 | Drug Discovery | Pre-Clinical Trials | 0000 000000 00 |
Bitterroot Bio | 07-Jun-2023 | Early Stage VC | 00000 | Drug Discovery | Generating Revenue | |
Mozart Therapeutics | 31-May-2023 | Early Stage VC | 0000 | Drug Discovery | Generating Revenue |
Alexandria Venture Investments Exits (116)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Korro Bio | 03-Nov-2023 | Reverse Merger | |
Lexeo Therapeutics | 03-Nov-2023 | 000 | 00000 |
Theonys | 17-Oct-2023 | 000 00 00000000 | |
Neumora | 15-Sep-2023 | 000 | 00000 |
RayzeBio | 15-Sep-2023 | 000 | 00000 |
Nanosys | 07-Sep-2023 | 000000000000000000 | |
DICE Therapeutics | 09-Aug-2023 | 000000000000000000 | 00.00 |
Haystack Oncology | 20-Jun-2023 | 000000000000000000 | 00000 |
Cibus | 01-Jun-2023 | Reverse Merger | |
Cardea | 29-Apr-2023 | Merger/Acquisition |
Alexandria Venture Investments Investments by Industry, Year, and Region
Alexandria Venture Investments Team (8)
Name | Title | Deals | Funds | Boards | Office |
---|---|---|---|---|---|
Jenna Foger | Senior Vice President, Science & Technology | 0 | Pasadena, CA | ||
Aaron Jacobson | Senior Vice President, Venture Counsel | Pasadena, CA | |||
Jeff Stevens | Vice President | 0 | 0 | Pasadena, CA | |
Joel Marcus JD | Founder & Executive Chairman of the Board of Directors | 00 | 0 | 00 | Pasadena, CA |
Alexandria Venture Investments Co-Investors (664)
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
ARCH Venture Partners | 25 | 0 | 0 |
![]() |
![]() |
Casdin Capital | 00 | 0 | 0 |
![]() |
![]() |
GV | 00 | 0 | 0 |
![]() |
![]() |
The Invus Group | 00 | 0 |
![]() |
![]() |
|
RA Capital Management | 00 | 0 | 0 |
![]() |
![]() |